Ebru Inan-Arioglu

Ankara, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs.

Cardiovascular Dysfunction in Type 2 Diabetes: The Role of MicroRNAs.

Journal: Handbook of experimental pharmacology

Published: May 11, 2026

Empagliflozin Protects Against Oxidative Stress in the Diabetic Brain by Inducing H2S Formation.

Empagliflozin Protects Against Oxidative Stress in the Diabetic Brain by Inducing H2S Formation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 07, 2025

β3-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation.

β3-Adrenoceptor Agonist Effects on the Urinary Bladder Beyond Detrusor Relaxation.

Journal: Neurourology and urodynamics

Published: March 10, 2025

Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes.

Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes.

Journal: International journal of molecular sciences

Published: July 11, 2024

Investigation of the Expression of CYP3A4 in Diabetic Rats in Xenobiotic Metabolism.

Investigation of the Expression of CYP3A4 in Diabetic Rats in Xenobiotic Metabolism.

Journal: Turkish journal of pharmaceutical sciences

Published: March 26, 2024

SGLT2 inhibitors: how do they affect the cardiac cells.

SGLT2 inhibitors: how do they affect the cardiac cells.

Journal: Molecular and cellular biochemistry

Published: October 27, 2023

Sex Differences in Glucose Homeostasis.

Sex Differences in Glucose Homeostasis.

Journal: Handbook of experimental pharmacology

Published: July 13, 2023

A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy.

A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy.

Journal: Pharmacology & therapeutics

Published: May 18, 2023

A comparison of urinary bladder weight in male and female mice across five models of diabetes and obesity.

A comparison of urinary bladder weight in male and female mice across five models of diabetes and obesity.

Journal: Frontiers in pharmacology

Published: December 07, 2022

Development of salting-out extraction methodology for the determination of piroxicam from polymeric based nanocarriers and biological samples.

Development of salting-out extraction methodology for the determination of piroxicam from polymeric based nanocarriers and biological samples.

Journal: Journal of pharmaceutical and biomedical analysis

Published: May 14, 2022

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement.

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement.

Journal: Frontiers in physiology

Published: April 19, 2022

Established and emerging treatments for diabetes-associated lower urinary tract dysfunction.

Established and emerging treatments for diabetes-associated lower urinary tract dysfunction.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 31, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026